
FDA approves duvelisib for adult patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma
The Food and Drug Administration has granted regular approval to duvelisib for adult patients with relapsed…
The Food and Drug Administration has granted regular approval to duvelisib for adult patients with relapsed…